Malignant Hypercalcemia: A Rare Etiology of Posterior Reversible Encephalopathy Syndrome

Posterior reversible encephalopathy syndrome (PRES) is a rare and severe neurotoxic encephalopathic state characterized by variable neurologic manifestations ranging from headache and confusion to seizures, coma, and reversible subcortical vasogenic edema on imaging. PRES is commonly induced by chronic renal failure, hypertension, chemotherapeutic drugs, and eclampsia. PRES induced by hypercalcemia is uncommon and not widely underlined in the literature. We underline a case of a 61-year-old female diagnosed with advanced breast carcinoma presented with altered sensorium and generalized limb weakness. She was found to have malignant hypercalcemia, and brain imaging demonstrated subcortical vasogenic edema in the occipital and frontal lobe, suggestive of PRES. Her condition gradually improved after the treatment of hypercalcemia.

[1]  H. Jeon,et al.  Posterior reversible encephalopathy syndrome in a patient with metastatic breast cancer: A case report , 2022, World journal of clinical cases.

[2]  A. Mirian,et al.  Hypercalcemia-Associated Posterior Reversible Encephalopathy Syndrome , 2021, The Neurohospitalist.

[3]  M. Shiroishi,et al.  Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging , 2020, Frontiers in Neurology.

[4]  Archana Hinduja Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome , 2020, Frontiers in Neurology.

[5]  M. Varma,et al.  Posterior reversible encephalopathy syndrome due to hypercalcaemia: a rare cause , 2019, BMJ Case Reports.

[6]  Sashank Prasad,et al.  Paraneoplastic PRES from lymphoma induced hypercalcemia: Case report and review of the literature , 2018, eNeurologicalSci.

[7]  A. Arunkumar,et al.  Clinical Features and Outcomes of Patients with Posterior Reversible Encephalopathy Syndrome , 2017, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[8]  E. Schmutzhard,et al.  Posterior reversible encephalopathy syndrome , 2017, Journal of Neurology.

[9]  A. Rabinstein,et al.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions , 2015, The Lancet Neurology.

[10]  D. Galarza-Delgado,et al.  Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  Sreenivasa Rao Sudulagunta,et al.  Posterior reversible encephalopathy syndrome (PRES). , 2008, International journal of obstetric anesthesia.

[12]  Charles L Truwit,et al.  Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. , 2007, AJR. American journal of roentgenology.

[13]  P. Striano,et al.  Posterior reversible encephalopathy syndrome in intensive care medicine , 2007, Intensive Care Medicine.

[14]  Y. Katayama,et al.  Posterior reversible encephalopathy syndrome due to hypercalcemia associated with parathyroid hormone-related peptide: a case report and review of the literature. , 2013, Internal medicine.

[15]  V. Kostic,et al.  [Posterior reversible encephalopathy syndrome]. , 2003, Srpski arhiv za celokupno lekarstvo.